The present disclosure relates to compositions and methods relating to the characterization of gene function. Specifically, the present disclosure provides transgenic mice comprising disruption in a trinucleotide repeat protein (TRP) gene. The present disclosure also provides methods of identifying agents that modulate TRP expression and function, useful models, and potential treatments for various disease states and disease conditions.